Similarly, teams like Chelsea and Manchester United have also seen success with their old guard players. Players like Cesar Azpilicueta and N'Golo Kante at Chelsea, as well as Cristiano Ronaldo and Bruno Fernandes at Manchester United, have been instrumental in their teams' strong performances. The understanding and chemistry built over multiple seasons have been key in the success of these teams.The establishment of the Application Algorithm Department represents a strategic investment in Xiaohongshu's long-term growth and competitiveness in the global market. By building a world-class team of algorithm experts and data scientists, the company is laying the foundation for future innovation and technological advancement that will drive sustainable growth and enable Xiaohongshu to stay ahead of the curve in the ever-evolving digital landscape.
NEW YORK--(BUSINESS WIRE)--Nov 21, 2024-- UBS Investment Bank today announced coupon payments for the ETRACS Alerian MLP Index ETN Series B (NYSE Arca: “AMUB”), traded on the NYSE Arca. * The table above provides a hyperlink to the relevant prospectus and supplements thereto. For more information on the ETRACS ETN, see “ List of ETNs ”. **"Current Yield (annualized)" equals the current Coupon Amount, multiplied by four (to annualize such coupon), divided by the Closing Indicative Value of the ETN on its current Coupon Valuation Date rounded to two decimal places for ease of analysis. The Current Yield is not indicative of future coupon payments, if any, on the ETN. You are not guaranteed any coupon or distribution amount under the ETN. About ETRACS ETRACS ETNs are senior unsecured notes issued by UBS AG, are traded on NYSE Arca, and can be bought and sold through a broker or financial advisor. An investment in ETRACS ETNs is subject to a number of risks, including the risk of loss of some or all of the investor’s principal, and is subject to the creditworthiness of UBS AG. Investors are not guaranteed any coupon or distribution amount under the ETNs . We urge you to read the more detailed explanation of risks described under “Risk Factors” in the applicable prospectus supplement for the ETRACS ETN. UBS AG has filed a registration statement (including a prospectus and supplements thereto) with the Securities and Exchange Commission, or SEC, for the offerings of securities to which this communication relates. Before you invest, you should read the prospectus, along with the applicable prospectus supplement to understand fully the terms of the securities and other considerations that are important in making a decision about investing in the ETRACS. The applicable offering document for the ETRACS ETN may be obtained by clicking on the name of the ETRACS ETN identified above. You may also get these documents without cost by visiting EDGAR on the SEC website at www.sec.gov . The securities related to the offerings are not deposit liabilities and are not insured or guaranteed by the Federal Deposit Insurance Corporation or any other governmental agency of the United States, Switzerland or any other jurisdiction. About UBS UBS is a leading and truly global wealth manager and the leading universal bank in Switzerland. It also provides diversified asset management solutions and focused investment banking capabilities. With the acquisition of Credit Suisse, UBS manages 5.7 trillion dollars of invested assets as per fourth quarter 2023. UBS helps clients achieve their financial goals through personalized advice, solutions and products. Headquartered in Zurich, Switzerland, the firm is operating in more than 50 markets around the globe. UBS Group shares are listed on the SIX Swiss Exchange and the New York Stock Exchange (NYSE). In the US, securities underwriting, trading and brokerage activities and M&A advisor activities are provided by UBS Securities LLC, a registered broker/dealer that is a wholly owned subsidiary of UBS AG, a member of the New York Stock Exchange and other principal exchanges, and a member of SIPC ( http://www.sipc.org/ ). UBS Financial Services Inc. is a registered broker/dealer and affiliate of UBS Securities LLC. This material is issued by UBS AG and/or any of its subsidiaries and/or any of its affiliates ("UBS"). This document was produced by and the opinions expressed are those of UBS as of the date of writing and are subject to change. It has been prepared solely for information purposes and for the use of the recipient. It does not constitute an offer or an invitation by or on behalf of UBS to any person to buy or sell any security. The information and analysis contained in this publication have been compiled or arrived at from sources believed to be reliable but UBS does not make any representation as to their accuracy or completeness and does not accept liability for any loss arising from the use hereof. Products and services mentioned in this material may not be available for residents of certain jurisdictions. Past performance is not necessarily indicative of future results. Please consult the restrictions relating to the product or service in question for further information. Alerian MLP Index and AMZ are trademarks of VettaFi and their use is granted under a license from VettaFi. VetttaFi owns and administers the Alerian Index Series. UBS specifically prohibits the redistribution or reproduction of this communication in whole or in part without the prior written permission of UBS and UBS accepts no liability whatsoever for the actions of third parties in this respect. © UBS 2024. The key symbol, UBS and ETRACS are among the registered and unregistered trademarks of UBS. Other marks may be trademarks of their respective owners. All rights reserved. View source version on businesswire.com : https://www.businesswire.com/news/home/20241121082975/en/ CONTACT: Media contact Alison Keunen +1-212-713-2296 alison.keunen@ubs.comInstitutional Investor contact1 +1-877-387 2275 KEYWORD: NEW YORK UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: BANKING PROFESSIONAL SERVICES FINANCE SOURCE: UBS Copyright Business Wire 2024. PUB: 11/21/2024 04:30 PM/DISC: 11/21/2024 04:28 PM http://www.businesswire.com/news/home/20241121082975/enThe world's tallest woman and the world's shortest woman have met for afternoon tea in London to celebrate Guinness World Records Day. Rumeysa Gelgi, who stands 215.16 centimeters (7 feet 0.7 inches) tall, and Jyoti Amge, who measures just 62.8 centimeters (2 feet 0.7 inches), met at the Savoy Hotel, according to a statement from Guinness World Records (GWR) on Wednesday. The height difference between the two women might be a massive 152.36 centimeters (5 feet), but the pair reportedly got on famously. "We do have things in common. We both love make-up, self-care, jewelry and doing our nails," said Gelgi in the statement. "It was difficult for us to make eye contact at times due to our height difference, but it was great," she added. Amge added that she was "so happy" to meet her fellow record holder. Gelgi, a web designer from Turkey, was confirmed as the tallest woman living in 2021. Her height is due to an extremely rare condition called Weaver syndrome. She was only the 27th person in the world to be diagnosed with the syndrome, according to GWR. Gelgi, 27, also holds the records for largest hands on a woman at 24.93 centimeters (9.81 inches); the longest back on a living person (female) at 59.90 centimeters (23.58 inches); and the longest ears on a person (female) at an average size of 9.58 centimeters (3.77 inches). Gelgi has also been featured in a GWR documentary named "Rumeysa: Walking Tall," which follows her on a journey across the U.S., meeting fellow record holders. Amge, an actress and media personality born in India, has a bone growth disorder named achondroplasia that affects the arms and legs. The disorder occurs early in a fetus' development in the womb and affects the cartilage tissue that should become a child's arms and legs. Despite her small stature, she is a big presence on social media and has also appeared on the U.S. television series "American Horror Story: Freak Show" in the role of Ma Petite. This means she is officially the shortest actress ever, GWR said. Amge has also appeared on the Italian TV show "Lo Show Dei Record" on various occasions. GWR editor-in-chief Craig Glenday met with the pair in London and said that the records are about "celebrating differences." "By bringing together these two amazing, iconic women, they can share their perspectives on life with each other and, also, with us," said Glenday in the statement. Both Gelgi and Amge have been named GWR ICONS, a new category introduced for the book's 2025 edition.
One of the key areas where Vivo's commitment to AI technology shines is in the realm of photography and imaging. Through the use of advanced AI algorithms, Vivo smartphones are able to capture stunning photos and videos with enhanced clarity, color accuracy, and detail. Whether it's portrait mode, night mode, or AI scene recognition, Vivo's AI-powered cameras ensure that every moment captured is picture-perfect, regardless of the shooting conditions.
Proteas qualify for World Test Championship final after thrilling win over PakistanWho Is Sudan's Interim Government Leader Bashir?
Kenny Dichter’s REAL SLX Is Getting Phygital With FanDuel, BetMGM
ITV I'm A Celebrity fans rumble 'real reason' all stars sent on trial amid camp tensionsThe trending topic on Weibo ignited a lively discussion among gamers, with many sharing their thoughts and speculations about the game's future updates and developments. Some even took the opportunity to showcase their favorite moments from the game or discuss strategies for tackling its toughest challenges.